002750 龙津药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.873-8.438-12.958-9.1830.485
总资产报酬率 ROA (%)-0.722-6.873-10.290-7.1280.371
投入资产回报率 ROIC (%)-0.861-8.367-12.764-9.0370.483

边际利润分析
销售毛利率 (%)64.50464.25360.88679.20531.070
营业利润率 (%)-90.118-66.207-94.589-45.785-0.777
息税前利润/营业总收入 (%)-88.157-71.058-96.358-56.456-0.680
净利润/营业总收入 (%)-82.868-70.662-97.274-59.796-1.062

收益指标分析
经营活动净收益/利润总额(%)125.58375.60581.12457.524134.710
价值变动净收益/利润总额(%)-13.555-13.781-6.319-11.734-155.382
营业外收支净额/利润总额(%)-10.7152.5620.37318.0851.930

偿债能力分析
流动比率 (X)7.9396.9547.6605.3744.610
速动比率 (X)7.2946.5047.0885.0574.320
资产负债率 (%)12.60213.96014.32919.06318.009
带息债务/全部投入资本 (%)-5.053-5.272-7.499-6.685-4.770
股东权益/带息债务 (%)-1,949.886-1,871.309-1,328.763-1,458.771-2,080.525
股东权益/负债合计 (%)663.705586.717565.572409.318428.999
利息保障倍数 (X)13.04022.84768.054100.230-6.094

营运能力分析
应收账款周转天数 (天)119.45956.52362.79578.96620.439
存货周转天数 (天)1,011.967382.593299.783427.16532.553